Christopher Adams, MD
Rheumatology · Auburn, ALNPI 1720039175
Payments from drug & device makers
Across 1,053 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$3K
- UCB, Inc.$2K
- Johnson & Johnson$1K
- Pfizer$1K
- GSK$1K
- plus $8K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 204 | $3,617 |
| AbbVie | 171 | $3,367 |
| UCB, Inc. | 116 | $2,008 |
| Johnson & Johnson(2 entities) | 61 | $1,393 |
| Pfizer | 72 | $1,384 |
| GSK | 57 | $1,194 |
| AstraZeneca(2 entities) | 50 | $1,189 |
| Mallinckrodt Hospital Products Inc. | 34 | $1,141 |
| Novartis | 47 | $809 |
| Radius Health, Inc. | 33 | $755 |
| E.r. Squibb & Sons, L.L.C. | 53 | $753 |
| ANI Pharmaceuticals, Inc. | 28 | $720 |
| Lilly USA, LLC | 39 | $685 |
| Aurinia Pharma U.S., Inc. | 18 | $477 |
| Sobi, Inc | 10 | $189 |
| Genentech USA, Inc. | 9 | $140 |
| Regeneron Healthcare Solutions, Inc. | 9 | $137 |
| Mallinckrodt Enterprises LLC | 4 | $103 |
| Sanofi | 3 | $81 |
| Boehringer Ingelheim | 2 | $68 |
| Kyowa Kirin, Inc. | 3 | $66 |
| Bristol Myers Squibb | 4 | $65 |
| Ferring Pharmaceuticals Inc. | 2 | $62 |
| Fresenius Kabi USA, LLC | 3 | $60 |
| Organon | 3 | $57 |
| Hikma Pharmaceuticals USA | 4 | $55 |
| CSL Behring | 2 | $53 |
| Medexus Pharma, Inc. | 4 | $52 |
| Tersera Therapeutics LLC | 2 | $43 |
| Antares Pharma, Inc. | 2 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
How this compares
$20,832 in reported general payments places this provider in the 70th percentile of 90 rheumatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Auburn
- Jose LeonAuburn$17K
- Zarmeena AliAuburn$8K
- Adahli MasseyAuburn$5K
- Jeffrey CurtisBirmingham$17.6M
- Kenneth SaagBirmingham$8.2M
- Vishala ChindaloreAnniston$3.5M
- Anthony TurkiewiczMountain Brk$2.5M
- Harry SchroederBirmingham$938K
- Jose Rubio MosqueraBirmingham$823K
- David McLainBirmingham$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.